<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    INMODE LTD.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About INMODE LTD.

    InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $447,000,000
    • SIC CODE
      3845
    • NIN CODE
      ####
    • LEADERSHIP
      Moshe Mizrahy
    • FOUNDED
      2008
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Bio-Path Holdings, Inc.

    Bio-Path Holdings, Inc.

    Bio-Path is a biotechnology company developing targeted therapies for acute myeloi...

    Bio-Path is a biotechnology company developing ...

    Filing Type:    PU
    TFF Pharmaceuticals, Inc.

    TFF Pharmaceuticals, Inc.

    Although intended for the lungs, many drugs are not given via the airway because d...

    Although intended for the lungs, many drugs are...

    Filing Type:    PU
    Eagle Pharmaceuticals, Inc.

    Eagle Pharmaceuticals, Inc.

    Eagle is a specialty pharmaceutical company working to advance safe and efficient ...

    Eagle is a specialty pharmaceutical company wor...

    Filing Type:    PU
    Biogen Inc.

    Biogen Inc.

    At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers...

    At Biogen, our mission is clear: we are pioneer...

    Filing Type:    PU
    Nuvectra Corporation

    Nuvectra Corporation

    NuvectraÂŽ is a neurostimulation company committed to helping physicians improve t...

    NuvectraÂŽ is a neurostimulation company commit...

    Filing Type:    PU
    Alterola Biotech, Inc.

    Alterola Biotech, Inc.

    Alterola Biotech Inc. provides medicinal delivery systems, offering nutraceutrical...

    Alterola Biotech Inc. provides medicinal delive...

    Utah Medical Products, Inc.

    Utah Medical Products, Inc.

    Utah Medical Products IncÂŽ, established in 1978, develops, manufactures and marke...

    Utah Medical Products IncÂŽ, established in 197...

    Filing Type:    PU
    HeartIn, Inc

    HeartIn, Inc

    Founded in 2014 in Miami, Florida, HeartIn Inc. is constantly driving innovations ...

    Founded in 2014 in Miami, Florida, HeartIn Inc....

    Amount Raised:    $18,137.00
    Fundraising Status:    EC
    Filing Type:    CF
    Smilelove LLC

    Smilelove LLC

    Smilelove offers clear aligner treatments direct-to-consumer: no expensive appoint...

    Smilelove offers clear aligner treatments direc...

    Amount Raised:    $704,405.00
    Fundraising Status:    SD
    Filing Type:    CF
    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc. was born out of a collaborative research effort developing...

    Virtuoso Surgical, Inc. was born out of a colla...

    Filing Type:    RA
    Merit Medical Systems, Inc.

    Merit Medical Systems, Inc.

    Founded in 1987, Merit Medical set out to build the world’s most customer-focuse...

    Founded in 1987, Merit Medical set out to build...

    Filing Type:    PU
    NuVasive, Inc.

    NuVasive, Inc.

    NuVasive is a world leader in minimally invasive, procedurally integrated spine so...

    NuVasive is a world leader in minimally invasiv...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.